Pharmacokinetic disposition of itraconazole in red-tailed hawks (Buteo jamaicensis)

Journal of Avian Medicine and Surgery

Volumn 14, Issue 1, 2000, Pages 15-22

  Jones, Michael P ^a   Orosz, Susan E ^a   Cox, Sherry K ^a   Frazier, Donita L ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Aspergillosis; Buteo jamaicensis; Itraconazole; Pharmacokinetics; Red tailed hawks

Indexed keywords

EID: 0010958627     PISSN: 10826742     EISSN: None     Source Type: Journal    
DOI: 10.1647/1082-6742(2000)014[0015:PDOIIR]2.0.CO;2     Document Type: Article

References (28)

1. Redig PT. Mycotic infections of birds of prey. In: Fowler ME, ed. Zoo and Wild Animal Medicine - Current Therapy 3. Philadelphia, PA: WB Saunders; 1993:178-181.
2. Forbes NA. Aspergillosis in raptors. Vet Rec. 1991;128:263.
3. Bauck L. Mycoses. In: Ritchie BW, Harrison GJ, Harrison LR, eds. Avian Medicine: Principles and Application. Lake Worth, FL: Wingers; 1994:997-1006.
4. Greenacre CB, Latimer KS, Ritchie BW. Leg paresis in a black palm cockatoo (Probosciger aterrimus) caused by aspergillosis. J Zoo Wildl Med. 1992;23:122-126.
5. Wolff PL, Petrini KR, Kolmstetter C. An outbreak of aspergillosis in crested wood partridges (Rollulus rouloul). J Zoo Wildl Med. 1992;23:108-112.
6. Graybill JR. New antifungal agents. Eur J Clin Microbiol Infect Dis. 1989;8:402-412.
7. Grant SM, Clissold SP. Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs. 1989;37:310-344.
8. Orosz SE, Frazier DL. Antifungal agents: a review of their pharmacology and therapeutic indications. J Avian Med Surg. 1995;9:8-18.
9. Hines RS, Sharkey P, Friday RB. Itraconazole treatment of pulmonary, ocular, and uropygial aspergillosis and candidiasis in birds - data from five clinical cases and controls. Proc Annu Conf Am Assoc Zoo Vet. 1990:322-327.
10. Forbes NA, Simpson GN, Goudswaard MF. Diagnosis of avian aspergillosis and treatment with itraconazole. Vet Rec. 1992;130:519-520.
11. Joseph V, Pappagianis D, Reavill DR. Clotrimazole nebulization for the treatment of respiratory aspergillosis. Proc Annu Conf Assoc Avian Vet. 1994:301-306.
12. Lumeij JT, Gorgeuska D, Worstenborghs R. Plasma and tissue concentrations of itraconazole in racing pigeons. J Avian Med Surg. 1995;9:32-35.
13. Orosz SE, Schroeder EC, Cox SK, et al. The effects of formulation on the systemic availability of itraconazole in pigeons. J Avian Med Surg. 1995;9:255-262.
14. Orosz SE, Frazier DL, Schroeder EC, et al. Pharmacokinetic properties of itraconazole in blue-fronted Amazon parrots (Amazona aestiva aestiva). J Avian Med Surg. 1996;10:168-173.
15. Herpol C. Influence de l'ago sur le pH dans le tube digestif de gallus domesticus. Ann Biol Anim Biochim Biophys. 1996;6:495.
16. Duke GE. Alimentary canal: secretion and digestion, special digestive functions, and absorption. In: Sturkie PD, ed. Avian Physiology. 4th ed. New York, NY: Springer Verlag; 1986:289-302.
17. Van Peer A, Woestenborghs R, Heykants J, et al. The effects of food and dose on the oral system availability of itraconazole in healthy subjects. Eur J Clin Pharmacol. 1989;36:423-426.
18. Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infections. J Am Acad Dermatol. 1987;17:220-223.
19. Barone JA, Koh JH, Bierman RH, et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother. 1993;37:778-784.
20. Stein A, Daneshmend TK, Warnock DW, et al. The effects of H2-receptor antagonists on the pharmacokinetics of itraconazole, a new oral antifungal. Br J Clin Pharmacol 1989;27:105-106.
21. Lim SG, Sawyer AM, Hudson M, et al. Short report: the absorption of fluconazole and itraconazole under conditions of low gastric acidity. In: Fromtling RA, ed. Recent Trends with the Discovery, Developments and Evaluation of Antifungal Agents. Barcelona, Spain: JR Prous; 1987:223-249.
22. Redig PT. Appendix ID: hematologic, biochemical and morphometric reference ranges of selected raptor species. In: Altman RB, Clubb SL, Dorrestein GM, Quesenberry K, eds. Avian Medicine and Surgery. Philadelphia, PA: WB Saunders; 1997:1020.
23. Cox SK, Orosz SE, Burnette J, Frazier D. Microassay for determination of itraconazole and hydroxyitraconazole in plasma and tissue biopsies. J Chromatogr B. 1997;702:175-180.
24. Boogaerts MA, Verhoef GE, Zachee P, et al. Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses. 1989;32:103-108.
25. Denning DW, Tucker RM, Hanson LG, Stevens DA. Itraconazole in opportunistic mycosis: cryptococcosis and aspergillosis. J Am Acad Dermatol. 1990;23:602-607.
26. Van Cutsem J, Van Gerven F, Janssen PAJ. Activity of orally, topically and parenterally administered it-raconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis. 1987;9:15-32.
27. Heykants J, Van Peer A, Van de Velde V, et al. The clinical pharmacokinetics of itraconazole: an overview. Mycoses. 1989;32:67-87.
28. Heykants J, Michiels M, Meuldermans W, et al. The pharmacokinetics of itraconazole in animals and man. An overview. In: Fromtling RA, ed. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. Barcelona, Spain: JR Prous; 1978:223-249.